Synthesis of radioiodinated naltrindole analogues

Ligands for studies of delta opioid receptors

Chris M. Kinter, John R. Lever

Research output: Contribution to journalArticle

Abstract

Analogues of naltrindole and N1′-methylnaltrindole having radioiodine in the 7′-position of the indole ring have been prepared for evaluation as delta opioid receptor ligands. The no-carrier-added radiosyntheses were conducted by Cu(I) assisted nucleophilic exchange of radioiodide for bromide under reducing conditions at 190 °C. A combination of HPLC and solid-phase extraction gave the 125I- or 123I-labeled products in satisfactory yields (47%) with high radiochemical purities (>98%) and high specific activities (125I: 43-68 GBq/μmol, 1155-1833 mCi/μmol; 123I: >92GBq/μmol, 2500mCi/μmol).

Original languageEnglish (US)
Pages (from-to)599-606
Number of pages8
JournalNuclear Medicine and Biology
Volume22
Issue number5
DOIs
StatePublished - 1995

Fingerprint

naltrindole
delta Opioid Receptor
Solid Phase Extraction
Bromides
High Pressure Liquid Chromatography
Ligands
indole

ASJC Scopus subject areas

  • Cancer Research
  • Molecular Medicine
  • Radiology Nuclear Medicine and imaging

Cite this

Synthesis of radioiodinated naltrindole analogues : Ligands for studies of delta opioid receptors. / Kinter, Chris M.; Lever, John R.

In: Nuclear Medicine and Biology, Vol. 22, No. 5, 1995, p. 599-606.

Research output: Contribution to journalArticle

@article{3b21db54a1c4407cb5beba7da215721f,
title = "Synthesis of radioiodinated naltrindole analogues: Ligands for studies of delta opioid receptors",
abstract = "Analogues of naltrindole and N1′-methylnaltrindole having radioiodine in the 7′-position of the indole ring have been prepared for evaluation as delta opioid receptor ligands. The no-carrier-added radiosyntheses were conducted by Cu(I) assisted nucleophilic exchange of radioiodide for bromide under reducing conditions at 190 °C. A combination of HPLC and solid-phase extraction gave the 125I- or 123I-labeled products in satisfactory yields (47{\%}) with high radiochemical purities (>98{\%}) and high specific activities (125I: 43-68 GBq/μmol, 1155-1833 mCi/μmol; 123I: >92GBq/μmol, 2500mCi/μmol).",
author = "Kinter, {Chris M.} and Lever, {John R.}",
year = "1995",
doi = "10.1016/0969-8051(94)00149-E",
language = "English (US)",
volume = "22",
pages = "599--606",
journal = "Nuclear Medicine and Biology",
issn = "0969-8051",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - Synthesis of radioiodinated naltrindole analogues

T2 - Ligands for studies of delta opioid receptors

AU - Kinter, Chris M.

AU - Lever, John R.

PY - 1995

Y1 - 1995

N2 - Analogues of naltrindole and N1′-methylnaltrindole having radioiodine in the 7′-position of the indole ring have been prepared for evaluation as delta opioid receptor ligands. The no-carrier-added radiosyntheses were conducted by Cu(I) assisted nucleophilic exchange of radioiodide for bromide under reducing conditions at 190 °C. A combination of HPLC and solid-phase extraction gave the 125I- or 123I-labeled products in satisfactory yields (47%) with high radiochemical purities (>98%) and high specific activities (125I: 43-68 GBq/μmol, 1155-1833 mCi/μmol; 123I: >92GBq/μmol, 2500mCi/μmol).

AB - Analogues of naltrindole and N1′-methylnaltrindole having radioiodine in the 7′-position of the indole ring have been prepared for evaluation as delta opioid receptor ligands. The no-carrier-added radiosyntheses were conducted by Cu(I) assisted nucleophilic exchange of radioiodide for bromide under reducing conditions at 190 °C. A combination of HPLC and solid-phase extraction gave the 125I- or 123I-labeled products in satisfactory yields (47%) with high radiochemical purities (>98%) and high specific activities (125I: 43-68 GBq/μmol, 1155-1833 mCi/μmol; 123I: >92GBq/μmol, 2500mCi/μmol).

UR - http://www.scopus.com/inward/record.url?scp=0029094002&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029094002&partnerID=8YFLogxK

U2 - 10.1016/0969-8051(94)00149-E

DO - 10.1016/0969-8051(94)00149-E

M3 - Article

VL - 22

SP - 599

EP - 606

JO - Nuclear Medicine and Biology

JF - Nuclear Medicine and Biology

SN - 0969-8051

IS - 5

ER -